Streetbeat News

Revenues

NTDOY

Nintendo Co., Ltd. (OTC:NTDOY) announced the launch of a next-gen gaming console to succeed the Switch within the fiscal year ending March 2025. Despite strong sales of the Switch, driven by titles like 'The Legend of Zelda: Tears of the Kingdom,' the company is preparing for a transition with the new console, which aims to address criticisms such as battery life. Nintendo plans to hold back major titles for the new device and has issued a takedown request for over 8,500 copies of the Yuzu emulator code.

Portfolio Pulse from Benzinga Neuro

May 07, 2024 | 12:48 pm

UMC

United Microelectronics Corporation (NYSE:UMC) reported a 6.9% year-over-year increase in April sales, reaching NT$19.741 billion. From January to April, revenues rose by 2.34% to NT$74.373 billion. The company also noted an 8.7% increase in April revenues compared to March. UMC's first-quarter CAPEX spending was $924 million, with a 2024 budget set at $3.3 billion. Co-president Jason Wang anticipates higher wafer shipments in Q2 due to improving inventory levels in various segments, despite near-term macro uncertainties and cost challenges. UMC's stock has seen a slight decline of over 0.8% in the past year, closing at $8.12 on Monday, down by 0.37%.

Portfolio Pulse from Nabaparna Bhattacharya

May 07, 2024 | 12:47 pm

GROM

Grom Social Enterprises Inc. (NASDAQ:GROM), a media, technology, and entertainment company, announced that its subsidiary, Top Draw Animation (TDA), has secured over $2.9M in new animation production assignments, including the largest single order in its 25-year history. These projects, supported by tax incentives from the Philippines, underscore TDA's role as a leading provider of premium animation services globally. Acquired by Grom in 2016, TDA offers high-capacity Harmony and Flash production pipelines and benefits from up to a 25% cash rebate for approved work in the Philippines.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:46 pm

OSIS

OSI Systems, Inc. (OSIS) announced a $6 million order from an advanced engineered solutions OEM for its Optoelectronics and Manufacturing division to provide electronic assemblies. CEO Deepak Chopra expressed commitment to supporting the OEM and anticipation for continued collaboration.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

ICCM

IceCure Medical (ICCM) is anticipated to receive a total of $13.2M from Terumo during the initial term, including $4M already received, $8.2M upon order completion, and $1M for milestone-based payments.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

ICCM

An independent study in Japan showed 0% breast cancer local recurrence 5 years after treatment with IceCure's ProSense, demonstrating its potential as a standard treatment for early-stage breast cancer. The study, published in Breast Cancer journal, highlighted excellent cosmetic outcomes, high patient satisfaction, and improved quality of life post-cryoablation. IceCure's distribution partner in Japan, Terumo Corporation, plans to submit a regulatory clearance application for ProSense in H2 2024. IceCure expects to receive a total of $13.2 million from Terumo for exclusive distribution rights in Japan.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:45 pm

RXST

RxSight shares surged following the announcement of better-than-expected Q1 financial results and an upward revision of its FY24 revenue guidance, surpassing estimates. Additionally, the positive outlook was reinforced as multiple firms increased their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:44 pm

BIOX

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) announced the approval of three new bio-insecticidal/bio-nematicidal solutions by Brazil's Ministry of Agriculture and Livestock. These solutions, derived from inactivated cells of the company's proprietary Burkholderia platform, mark a significant regulatory milestone in Brazil, the world's leading bio-control market. This approval enables the commercialization of these products in Brazil, potentially opening the door for future product launches. Bioceres' bio-control solutions are commercialized under the Rizobacter brand and other third-party brands in Brazil. The company's CEO, Federico Trucco, highlighted the approval as a key milestone for growth in Brazil and noted the global relevance of this market to the company.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:43 pm

CWD

Caliber (NASDAQ:CWD), a real estate investor, developer, and manager, announced the sale of a 50-acre parcel in Johnstown, Colorado, to the Archdiocese of Denver for $7.7 million. The land, part of a larger 190-acre purchase in June 2021, is intended for a new Catholic high school. This sale is part of Caliber's Johnstown Development, a 750-acre master-planned project. The development is expected to include multifamily, retail, and industrial spaces, aiming to boost the Northern Colorado area's growth and investment.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:41 pm

BLDP

Ballard Power Systems anticipates its 2024 revenue to be heavily weighted towards the second half of the year, mirroring its 2023 pattern, with about 30% expected in the first half and 70% in the latter half. The company has not provided specific revenue or net income guidance for 2024 due to the nascent stage of the hydrogen fuel cell market. Ballard's projected total operating expenses for 2024 are between $145 million and $165 million, with capital expenditures estimated to be between $50 million and $70 million.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 12:40 pm